Home/Empros Pharma/Halide Shala

HS

Halide Shala

Controller

Therapeutic Areas

Obesity Metabolic Disease

Empros Pharma Pipeline

Drug	Indication	Phase
EMP16	Weight-loss maintenance in obesity	Phase 2

Leadership Team at Empros Pharma

Arvid Söderhäll

Chief Executive Officer

Chief Scientific Officer, Co-founder

Chief Technology Officer & Head of Quality Assurance

Business Developer

View full Empros Pharma profile